← Back to Search

Ultrasound for Prostate Cancer

Phase 1

Waitlist Available

Led By Hossein Jadvar, MD

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial uses 18F-FMAU PET/CT to scan for prostate cancer. The tracer is given through a vein and helps to take pictures of areas inside the body where the tracer is taken up. This may help find the cancer and see how far the disease has spread.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of men for whom biopsy cores taken based only on the 18F-FMAU PET/CT results would have yielded the same overall diagnosis as the standard TRUS-guided core or the mpMRI-directed prostate biopsies

Malignant Neoplasms

Proportion of men who completed both imaging procedures and for whom biopsy cores taken based only on the fluorine 18F-FMAU PET/CT results would have yielded the same overall diagnosis as the standard TRUS-guided core prostate biopsies

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (18F-FMAU PET/CT)Experimental Treatment6 Interventions

Patients receive radiotracer F 18 d-FMAU IV over 1 minute and then undergo 18F-FMAU PET/CT on day 1. Patients then undergo standard of care multiparametic MRI and standard of care transrectal ultrasound-guided biopsy.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CAT

2022

N/A

~1860

Ultrasound

2013

Completed Phase 1

~1950

Positron Emission Tomography

2008

Completed Phase 2

~2240

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

905 Previous Clinical Trials

1,596,300 Total Patients Enrolled

18 Trials studying Prostate Cancer

9,422 Patients Enrolled for Prostate Cancer

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,135 Total Patients Enrolled

561 Trials studying Prostate Cancer

507,173 Patients Enrolled for Prostate Cancer

National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH

89 Previous Clinical Trials

19,766 Total Patients Enrolled

5 Trials studying Prostate Cancer

175 Patients Enrolled for Prostate Cancer

Media Library

Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT02809690 — Phase 1

Prostate Cancer Research Study Groups: Diagnostic (18F-FMAU PET/CT)

Prostate Cancer Clinical Trial 2023: Ultrasound Highlights & Side Effects. Trial Name: NCT02809690 — Phase 1

Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT02809690 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there other case studies that have explored the potential of Ultrasound in medical treatment?

"Currently, 2 clinical studies involving Ultrasound are in progress with none at Phase 3. These trials are being conducted primarily in Los Angeles but other locations exist to participate as well."

Answered by AI

What is the upper limit for patient participation in this clinical trial?

"This clinical trial has concluded its recruitment process as the latest update was issued in August of 2022. Should you seek similar trials, there are 1252 studies actively looking for participants with neoplasms and 2 ultrasound-related medical trials that require volunteers."

Answered by AI

What potential hazards could arise from the use of Ultrasound?

"With limited data to evaluate its efficacy and safety, our team at Power assigned ultrasound a rating of 1."

Answered by AI

Are there opportunities for current enrolment in this clinical trial?

"Notably, clinicaltrials.gov indicates that this particular trial is not presently accepting subjects. Initially posted on September 12th of 2016, the study was last edited on August 19th 2022; however, there are currently over one-thousand two hundred and fifty four other studies enlisting patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

2016. "18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02809690.